Von Hippel-Lindau Syndrome

What Von Hippel-Lindau Syndrome Means

Von Hippel-Lindau syndrome, often called VHL, is a rare inherited disorder that causes growths called tumors and cysts to develop in different parts of the body. These growths can appear in the brain, spinal cord, eyes, kidneys, pancreas, adrenal glands, and reproductive organs. Most of these tumors are benign, meaning they are not cancer, but some can become malignant (cancerous), especially in the kidneys and pancreas. VHL happens because of a change (mutation) in a gene called the VHL gene, which normally helps control cell growth. When this gene doesn’t work properly, cells can grow out of control, leading to tumors.

Why Von Hippel-Lindau Syndrome Matters in Cancer Care

People with VHL have a higher risk of developing certain cancers, particularly a type of kidney cancer called clear cell renal cell carcinoma, which is the most common kidney cancer in adults. Because VHL affects many organs, it requires careful and ongoing medical monitoring to find tumors early and manage them before they cause serious problems. Early detection can help doctors plan treatments that may include surgery or other therapies to remove or control tumors. Knowing about VHL can also help family members understand their own risks, since the condition is inherited.

What Patients Might See or Experience

Symptoms of VHL can vary widely depending on which organs are affected. Common signs include vision changes from tumors in the eyes, headaches or balance problems from brain or spinal tumors, and symptoms related to kidney or pancreatic tumors. Some people may not have symptoms for many years, and tumors might be found during routine imaging tests. Because VHL can cause many different problems, people with this syndrome often see several specialists and have regular check-ups to watch for new growths.

Where the Term Might Appear

You might see the term Von Hippel-Lindau syndrome or its other names—VHL disease, VHL syndrome, or von Hippel-Lindau disease—in medical records, genetic testing reports, treatment plans, or when discussing risks for certain cancers. It may also appear in information about specific drugs approved for VHL-related kidney cancer, such as belzutifan (Welireg). Understanding the different names can help you recognize when your care team is referring to this condition.

What Von Hippel-Lindau Syndrome Does Not Automatically Mean

Having VHL does not mean a person currently has cancer or will definitely develop cancer. It means there is a higher risk, and tumors may be benign or slow-growing. Each person’s experience with VHL is unique, and many live with the condition for years with careful monitoring and treatment. A diagnosis of VHL also does not predict exactly how the disease will progress or which organs will be affected.

Questions to Ask Your Care Team

If you or a loved one has VHL, it can be helpful to ask your healthcare providers questions like: What types of tumors should we watch for? How often should I have imaging tests? Are there treatments to prevent tumors from growing? Should family members be tested for VHL? What symptoms should I report right away? These questions can help you understand your care plan and what to expect.

Understanding the Term in Context

Because VHL has several names and can involve many different tumors, it’s important to look at the full medical report or discussion to understand what it means for you. If you see the term in a test result or treatment plan, ask your care team to explain how it applies to your situation. This entry is for education and does not replace personalized medical advice.

Next Steps for Patients and Caregivers

If Von Hippel-Lindau syndrome is mentioned in your care, the best next step is to talk with your healthcare team about what it means for you or your loved one. They can explain the risks, recommend appropriate tests, and help plan monitoring or treatment. Genetic counseling may also be offered to discuss family risks and testing options. Staying informed and involved in your care can help manage VHL effectively.